Found 319 results for bank-of-america-merril-lynch

Animal Feed Tombstone

Custom tombstone recognizing the acquisition of Hamlet Protein. The Danish provider of soy-based young animal feed was purchased by Altor and Goldman Sachs Merchant Banking Division.

(5LAC786)
1 Image

Custom Mission Statement Display

Custom mission statement display designed for BlackArch Partners. The investment bank is based in Charlotte, North Carolina.

(5ARA664)
1 Image

Benziger Family Winery Deal Gift

Deal gift commemorating the acquisition by The Wine Group of the Benziger Family Winery, located in Glen Ellen, California. Benziger was advised by San Francisco-based investment bank the Demeter Group.

(5AKL619)
1 Image

Real Estate Loan Portfolio Tombstone

Custom tombstone marking the acquisition of a commercial property loan portfolio. Acquisition  of the Project Poseidon portfolio was made by a consortium formed by Goldman Sachs, CarVal Investors, and Bank of Ireland.

(6LAC877)
1 Image

Payment Processor Deal Tombstone

Deal tombstone marking the acquisition of Munich, Germany-based payments processor PAY.ON. Acquirer, Florida-based ACI Worldwide, is a provider of e-payment and banking solutions.

(6LAC918)
1 Image

Wine Bottle-Themed Deal Toy

Wine bottle-themed deal toy marking the sale by GE Capital of its Australia and New Zealand consumer finance business. The sale was made to a consortium comprised of Varde Partners, Deustche Bank, and KKR.

(5SSC748)
1 Image

Legal Advisory Deal Tombstone

Deal tombstone commemorating Shearman & Sterling’s legal advisory role in the purchase of an interest in an office building portfolio. The stake in 11 New York City office properties was acquired by Norway’s Norges Bank.

1 Image

Lucite Tombstone for Acrylic Manufacturer

Custom Lucite tombstone marking the acquisition by Charlesbank Capital Partners of Plaskolite. Based in Columbus, Ohio, Plaskolite manufactures acrylic sheet products.

(6AKL745)
1 Image

Molecule-Themed Biotech Deal Toy

Custom deal toy commemorating the initial public offering of Spring Bank Pharmaceuticals, a clinical-stage biopharmaceutical company based in Hopkinton, Massachusetts. The firm has focused on small-molecule therapies for hepatitis B and viral diseases.

(6AKLA83)
1 Image